Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Inventory (2016 - 2025)

Fortress Biotech (FBIO) has 10 years of Inventory data on record, last reported at $12.6 million in Q3 2025.

  • For Q3 2025, Inventory rose 6.68% year-over-year to $12.6 million; the TTM value through Sep 2025 reached $12.6 million, up 6.68%, while the annual FY2024 figure was $14.9 million, 46.42% up from the prior year.
  • Inventory reached $12.6 million in Q3 2025 per FBIO's latest filing, down from $13.6 million in the prior quarter.
  • Across five years, Inventory topped out at $16.1 million in Q1 2022 and bottomed at $2.3 million in Q1 2021.
  • Average Inventory over 5 years is $12.2 million, with a median of $12.5 million recorded in 2025.
  • Peak YoY movement for Inventory: skyrocketed 1084.04% in 2021, then fell 27.92% in 2023.
  • A 5-year view of Inventory shows it stood at $9.9 million in 2021, then soared by 43.57% to $14.2 million in 2022, then dropped by 27.92% to $10.2 million in 2023, then skyrocketed by 46.42% to $14.9 million in 2024, then fell by 15.85% to $12.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $12.6 million in Q3 2025, $13.6 million in Q2 2025, and $12.5 million in Q1 2025.